Liver transplantation for metabolic liver diseases in adults: indications and outcome
1Department of Gastroenterology, University of Heidelberg, Germany and 2Department of Surgery, University of Heidelberg, Germany
Correspondence to: Uta Merle, University Hospital Heidelberg—Department of Internal Medicine IV, Im Neuenheimer Feld 410 - 69120 Heidelberg—Germany. Email: uta_merle{at}med.uni-heidelberg.de
 |
Abstract |
|---|
Orthotopic liver transplantation is the preferred treatment for many patients with complications of end-stage liver disease. For metabolic liver diseases liver transplantation does not only replace the diseased organ, but also can potentially correct the metabolic defect. Results of liver transplantation for metabolic diseases have been encouraging. In Wilson's disease liver transplantation is considered an effective treatment for the fulminant form and for end-stage liver disease, associated with an excellent long-term outcome. However, it is still a matter of controversy whether liver transplantation should be considered in Wilson's disease patients with severe neurological impairment. Liver transplantation for hereditary haemochromatosis is relatively uncommon and is associated with a decreased post-transplantation patient survival, most likely due to infections and cardiac complications. Reduction of iron overload prior to liver transplantation in patients with hereditary haemochromatosis might be associated with a better outcome.
Keywords: haemochromatosis; liver transplantation; metabolic diseases; Wilson's disease